January 14, 2014
From: Tanya Samazan [mailto:tsamazan@strategic-directions.com] Agreement supports further development of organoids as next-generation drug screening platform Utrecht,- The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture [...]
Stratos Genomics Announces Major Molecular Engineering Achievement
January 14, 2014
Seattle, Wash. – Stratos Genomics Inc. today announced it has achieved a break-through in the reduction of the SBX™ (Sequencing by Expansion™) probe library. The original commercialization path for SBX was a 256 tetramer probe library. An undisclosed $2 million Series A-5 funding closed in the fall of 2013 based on demonstrated sequence reads of [...]
Optibrium Announces a New Release of StarDrop Introducing MPO Explorer
January 14, 2014
CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the release of a new version of its StarDrop™ software platform. The latest release introduces MPO Explorer™, which provides innovative new methods to guide ‘strategic’ decisions in research programmes, by helping to identify the key properties and selection criteria with which to [...]
llumina Launches the NextSeq™ 500 Sequencing System
January 14, 2014
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced the immediate availability of a transformative addition to its industry-leading next-generation sequencing portfolio with the launch of the NextSeq 500 System. The new sequencer packs high-throughput performance into an affordable desktop form factor, enabling researchers to perform the most popular sequencing applications in less than a day. [...]
Organovo Announces Collaboration with National Institutes of Health
January 14, 2014
SAN DIEGO and BETHESDA, Md. -- Organovo announced today that they are joining together with two institutes from the National Institutes of Health (NIH) to help scientists develop more reliable tools for bringing safer, more effective treatments to patients on a faster timeline. Organovo is collaborating with the National Center for Advancing Translational Sciences (NCATS) [...]
Protein Precipitation Sample Preparation Kit
January 14, 2014
The Combipack™ from Porvair Sciences has been introduced for laboratories tasked with protein precipitation sample preparation. Comprising five colour coded Porvair P3 protein precipitation plates and five 1ml deep well collection plates the Combipack™ contains all the elements required to accelerate the traditionally troublesome procedure at a budget price. Biological samples commonly contain proteins that [...]
Datacolor Pioneers Digital Color Communication with Introduction of 45/0 Handhelds
January 14, 2014
Datacolor®, a global leader in color management solutions, today announced the availability of the Datacolor 45 family of hand-held, high-accuracy, spectrophotometers with best-in-class repeatability and industry leading inter-instrument agreement. Developed to address the specific needs of color supply chains, the Datacolor 45 handhelds enable color appearance control with confidence, ease-of-use and value while improving the [...]
VOLKER DREISBACH NAMED VICE PRESIDENT, ASIA
January 14, 2014
Berwyn, PA - AMETEK, Inc. (NYSE:AME) today announced the appointment of Volker Dreisbach as Vice President, Asia. He replaces Lim Meng Kee, who retires after 21 years with the Company. “Volker brings extensive international experience to his new position, and we expect him to play a key role in the continued growth and success of [...]
Bioline Expands into Singapore
January 14, 2014
CINCINNATI -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the opening of an office in Singapore to support and grow the Bioline business in Singapore and in Asia. With the opening of the new office; Bioline will provide direct sales, technical support, and training to its [...]
Danaher CEO to Comment on Financial Performance
January 14, 2014
Washington, D.C.- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's fourth quarter 2013 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2013 adjusted diluted net earnings per [...]

